2014
DOI: 10.1038/nchembio.1669
|View full text |Cite
|
Sign up to set email alerts
|

A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation

Abstract: Because of the critical role of neuroinflammation in various neurological diseases, there are continuous efforts to identify new therapeutic targets as well as new therapeutic agents to treat neuroinflammatory diseases. Here we report the discovery of inflachromene (ICM), a microglial inhibitor with anti-inflammatory effects. Using the convergent strategy of phenotypic screening with early stage target identification, we show that the direct binding target of ICM is the high mobility group box (HMGB) proteins.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
121
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 103 publications
(131 citation statements)
references
References 30 publications
(45 reference statements)
6
121
1
Order By: Relevance
“…Confirming our observations of disrupted Troma-I expression in the GIT2KO model it has also been demonstrated that reductions in Troma-I can also modulate HMGCS2 expression and in doing so modulate energy metabolism and ketogenic activity [103]. HMGB2 is also critically involved in regulatory mechanisms that, control DNA damage [125], cell senescence [126], innate immune responses and neuroinflammation [127, 128] as well as stem cell proliferation and neurogenesis [129]. In addition to the specific GIT2-dependent alteration of HMG proteins multiple additional proteins that regulate age-related energy metabolism (Prcp [130], age-related DNA damage (Bach2 [131], age-related hematopoietic network regulation (Irf8 [132], immunosenescence (Pecam1 [133] and ER stress/amyloid related regulation of insulin secretion (Herpud1 [134-136]) were altered in GIT2KOs.…”
Section: Discussionsupporting
confidence: 72%
“…Confirming our observations of disrupted Troma-I expression in the GIT2KO model it has also been demonstrated that reductions in Troma-I can also modulate HMGCS2 expression and in doing so modulate energy metabolism and ketogenic activity [103]. HMGB2 is also critically involved in regulatory mechanisms that, control DNA damage [125], cell senescence [126], innate immune responses and neuroinflammation [127, 128] as well as stem cell proliferation and neurogenesis [129]. In addition to the specific GIT2-dependent alteration of HMG proteins multiple additional proteins that regulate age-related energy metabolism (Prcp [130], age-related DNA damage (Bach2 [131], age-related hematopoietic network regulation (Irf8 [132], immunosenescence (Pecam1 [133] and ER stress/amyloid related regulation of insulin secretion (Herpud1 [134-136]) were altered in GIT2KOs.…”
Section: Discussionsupporting
confidence: 72%
“…A high percentage of the identified UPF1-regulated genes such as S100A9, CDC42, HMGB2 and members of 14-3-3 protein family are related to cell differentiation and inflammation19202122232425. In order to investigate the mechanism behind the UPF1 effects we selected S100A9, an important regulator for myeloid cell functions, for further analysis26.…”
Section: Resultsmentioning
confidence: 99%
“…Though not itself a transcription factor, high mobility group protein B1 (HMG1) is a DNA-binding protein that regulates gene transcription through its interactions with nucleosomes, transcription factors and histones 142144 . Crucially, HMG1 is involved in proinflammatory cytokine gene transcription 143 and is secreted by haem-stimulated microglia in vitro 145 .…”
Section: Modulators Of Microglial Polarizationmentioning
confidence: 99%